BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 28077264)

  • 1. Self-assembly of green tea catechin derivatives in nanoparticles for oral lycopene delivery.
    Li W; Yalcin M; Lin Q; Ardawi MM; Mousa SA
    J Control Release; 2017 Feb; 248():117-124. PubMed ID: 28077264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP; Jain K; Jain NK
    Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lycopene loaded whey protein isolate nanoparticles: An innovative endeavor for enhanced bioavailability of lycopene and anti-cancer activity.
    Jain A; Sharma G; Ghoshal G; Kesharwani P; Singh B; Shivhare US; Katare OP
    Int J Pharm; 2018 Jul; 546(1-2):97-105. PubMed ID: 29715533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (-)-epigallocatechin gallate.
    Dube A; Nicolazzo JA; Larson I
    Eur J Pharm Sci; 2010 Oct; 41(2):219-25. PubMed ID: 20600878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The activity against Ehrlich's ascites tumors of doxorubicin contained in self assembled, cell receptor targeted nanoparticle with simultaneous oral delivery of the green tea polyphenol epigallocatechin-3-gallate.
    Ray L; Kumar P; Gupta KC
    Biomaterials; 2013 Apr; 34(12):3064-76. PubMed ID: 23357370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan nanoparticles enhance the plasma exposure of (-)-epigallocatechin gallate in mice through an enhancement in intestinal stability.
    Dube A; Nicolazzo JA; Larson I
    Eur J Pharm Sci; 2011 Oct; 44(3):422-6. PubMed ID: 21925598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
    Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
    ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, development, and characterization of lipid nanocarriers-based epigallocatechin gallate delivery system for preventive and therapeutic supplementation.
    Frias I; Neves AR; Pinheiro M; Reis S
    Drug Des Devel Ther; 2016; 10():3519-3528. PubMed ID: 27826184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the effectiveness of (-)-epigallocatechin gallate (EGCG) against rabbit atherosclerosis by EGCG-loaded nanoparticles prepared from chitosan and polyaspartic acid.
    Hong Z; Xu Y; Yin JF; Jin J; Jiang Y; Du Q
    J Agric Food Chem; 2014 Dec; 62(52):12603-9. PubMed ID: 25483592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of PLGA nanoparticles of tea polyphenols and their strong in vivo protective effect against chemically induced DNA damage.
    Srivastava AK; Bhatnagar P; Singh M; Mishra S; Kumar P; Shukla Y; Gupta KC
    Int J Nanomedicine; 2013; 8():1451-62. PubMed ID: 23717041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daunorubicin oral bioavailability enhancement by surface coated natural biodegradable macromolecule chitosan based polymeric nanoparticles.
    Ahmad N; Ahmad R; Alam MA; Ahmad FJ; Amir M; Pottoo FH; Sarafroz M; Jafar M; Umar K
    Int J Biol Macromol; 2019 May; 128():825-838. PubMed ID: 30690115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model.
    Cano A; Ettcheto M; Chang JH; Barroso E; Espina M; Kühne BA; Barenys M; Auladell C; Folch J; Souto EB; Camins A; Turowski P; García ML
    J Control Release; 2019 May; 301():62-75. PubMed ID: 30876953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folate-targeted nanostructured lipid carriers for enhanced oral delivery of epigallocatechin-3-gallate.
    Granja A; Vieira AC; Chaves LL; Nunes C; Neves AR; Pinheiro M; Reis S
    Food Chem; 2017 Dec; 237():803-810. PubMed ID: 28764070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of lycopene micelle and lycopene chylomicron and a comparison of bioavailability.
    Chen YJ; Inbaraj BS; Pu YS; Chen BH
    Nanotechnology; 2014 Apr; 25(15):155102. PubMed ID: 24651082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucoadhesive chitosan-coated PLGA nanoparticles for oral delivery of ferulic acid.
    Lima IA; Khalil NM; Tominaga TT; Lechanteur A; Sarmento B; Mainardes RM
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):993-1002. PubMed ID: 29842790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model.
    Khan N; Bharali DJ; Adhami VM; Siddiqui IA; Cui H; Shabana SM; Mousa SA; Mukhtar H
    Carcinogenesis; 2014 Feb; 35(2):415-23. PubMed ID: 24072771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of collagen peptide functionalized chitosan nanoparticles by ionic gelation method: An effective carrier system for encapsulation and release of doxorubicin for cancer drug delivery.
    Anandhakumar S; Krishnamoorthy G; Ramkumar KM; Raichur AM
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):378-385. PubMed ID: 27770906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
    Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
    Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of oral bioavailability of salmon calcitonin through chitosan-modified, dual drug-loaded nanoparticles.
    Liu L; Yang H; Lou Y; Wu JY; Miao J; Lu XY; Gao JQ
    Int J Pharm; 2019 Feb; 557():170-177. PubMed ID: 30597264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral insulin delivery, the challenge to increase insulin bioavailability: Influence of surface charge in nanoparticle system.
    Czuba E; Diop M; Mura C; Schaschkow A; Langlois A; Bietiger W; Neidl R; Virciglio A; Auberval N; Julien-David D; Maillard E; Frere Y; Marchioni E; Pinget M; Sigrist S
    Int J Pharm; 2018 May; 542(1-2):47-55. PubMed ID: 29501738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.